Transfer Learning-Based Multi-Scale Denoising Convolutional Neural Network for Prostate Cancer Detection

The analysis of art design under improved convolutional neural network based on the Internet of Things technology

This work aims to explore the application of an improved convolutional neural network (CNN) combined with Internet of Things (IoT) technology in art design education and teaching. The development of IoT technology has created new opportunities for art design education, while deep learning and improved CNN models can provide more accurate and effective tools for image processing and analysis. In order to enhance the effectiveness of art design teaching and students' creative expression, this work proposes an improved CNN model. In model construction, it increases the number of convolutional layers and neurons, and incorporates the batch normalization layer and dropout layer to enhance feature extraction capabilities and reduce overfitting. Besides, this work creates an experimental environment using IoT technology, capturing art image samples and environmental data using cameras, sensors, and other devices. In the model application phase, image samples undergo preprocessing and are input into the CNN for feature extraction. Sensor data are concatenated with image feature vectors and input into the fully connected layers to comprehensively understand the artwork. Finally, this work trains the model using techniques such as cross-entropy loss functions and L2 regularization and adjusts hyperparameters to optimize model performance. The results indicate that the improved CNN model can effectively acquire art sample data and student creative expression data, providing accurate and timely feedback and guidance for art design education and teaching, with promising applications. This work offers new insights and methods for the development of art design education.

Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer

Histopathology, which is the gold-standard for prostate cancer diagnosis, faces significant challenges. With prostate cancer ranking among the most common cancers in the United States and worldwide, pathologists experience an increased number for prostate biopsies. At the same time, precise pathological assessment and classification are necessary for risk stratification and treatment decisions in prostate cancer care, adding to the challenge to pathologists. Recent advancement in digital pathology makes artificial intelligence and learning tools adopted in histopathology feasible. In this review, we introduce the concept of AI and its various techniques in the field of histopathology. We summarize the clinical applications of AI pathology for prostate cancer, including pathological diagnosis, grading, prognosis evaluation, and treatment options. We also discuss how AI applications can be integrated into the routine pathology workflow. With these rapid advancements, it is evident that AI applications in prostate cancer go beyond the initial goal of being tools for diagnosis and grading. Instead, pathologists can provide additional information to improve long-term patient outcomes by assessing detailed histopathologic features at pixel level using digital pathology and AI. Our review not only provides a comprehensive summary of the existing research but also offers insights for future advancements.

Comprehensive Assessment of MRI-based Artificial Intelligence Frameworks Performance in the Detection, Segmentation, and Classification of Prostate Lesions Using Open-Source Databases

Numerous MRI-based artificial intelligence (AI) frameworks have been designed for prostate cancer lesion detection, segmentation, and classification via MRI as a result of intrareader and interreader variability that is inherent to traditional interpretation. Open-source data sets have been released with the intention of providing freely available MRIs for the testing of diverse AI frameworks in automated or semiautomated tasks. Here, an in-depth assessment of the performance of MRI-based AI frameworks for detecting, segmenting, and classifying prostate lesions using open-source databases was performed. Among 17 data sets, 12 were specific to prostate cancer detection/classification, with 52 studies meeting the inclusion criteria.

Quality of T2-weighted MRI re-acquisition versus deep learning GAN image reconstruction: A multi-reader study

PURPOSE

To evaluate CycleGAN's ability to enhance T2-weighted image (T2WI) quality.

METHOD

A CycleGAN algorithm was used to enhance T2WI quality. 96 patients (192 scans) were identified from patients who underwent multiple axial T2WI due to poor quality on the first attempt (RAD1) and improved quality on re-acquisition (RAD2). CycleGAN algorithm gave DL classifier scores (0-1) for quality quantification and produced enhanced versions of QI1 and QI2 from RAD1 and RAD2, respectively. A subset (n = 20 patients) was selected for a blinded, multi-reader study, where four radiologists rated T2WI on a scale of 1-4 for quality. The multi-reader study presented readers with 60 image pairs (RAD1 vs RAD2, RAD1 vs QI1, and RAD2 vs QI2), allowing for selecting sequence preferences and quantifying the quality changes.

RESULTS

The DL classifier correctly discerned 71.9 % of quality classes, with 90.6 % (96/106) as poor quality and 48.8 % (42/86) as diagnostic in original sequences (RAD1, RAD2). CycleGAN images (QI1, QI2) demonstrated quantitative improvements, with consistently higher DL classifier scores than original scans (p < 0.001). In the multi-reader analysis, CycleGAN demonstrated no qualitative improvements, with diminished overall quality and motion in QI2 in most patients compared to RAD2, with noise levels remaining similar (8/20). No readers preferred QI2 to RAD2 for diagnosis.

CONCLUSION

Despite quantitative enhancements with CycleGAN, there was no qualitative boost in T2WI diagnostic quality, noise, or motion. Expert radiologists didn't favor CycleGAN images over standard scans, highlighting the divide between quantitative and qualitative metrics.

Multiround Transfer Learning and Modified Generative Adversarial Network for Lung Cancer Detection

Lung cancer has been the leading cause of cancer death for many decades. With the advent of artificial intelligence, various machine learning models have been proposed for lung cancer detection (LCD). Typically, challenges in building an accurate LCD model are the small-scale datasets, the poor generalizability to detect unseen data, and the selection of useful source domains and prioritization of multiple source domains for transfer learning. In this paper, a multiround transfer learning and modified generative adversarial network (MTL-MGAN) algorithm is proposed for LCD. The MTL transfers the knowledge between the prioritized source domains and target domain to get rid of exhaust search of datasets prioritization among multiple datasets, maximizing the transferability with a multiround transfer learning process, and avoiding negative transfer via customization of loss functions in the aspects of domain, instance, and feature. In regard to the MGAN, it not only generates additional training data but also creates intermediate domains to bridge the gap between the source domains and target domains. 10 benchmark datasets are chosen for the performance evaluation and analysis of the MTL-MGAN. The proposed algorithm has significantly improved the accuracy compared with related works. To examine the contributions of the individual components of the MTL-MGAN, ablation studies are conducted to confirm the effectiveness of the prioritization algorithm, the MTL, the negative transfer avoidance via loss functions, and the MGAN. The research implications are to confirm the feasibility of multiround transfer learning to enhance the optimal solution of the target model and to provide a generic approach to bridge the gap between the source domain and target domain using MGAN.

A hybrid cancer prediction based on multi-omics data and reinforcement learning state action reward state action (SARSA)

These days, the ratio of cancer diseases among patients has been growing day by day. Recently, many cancer cases have been reported in different clinical hospitals. Many machine learning algorithms have been suggested in the literature to predict cancer diseases with the same class types based on trained and test data. However, there are many research rooms available for further research. In this paper, the studies look into the different types of cancer by analyzing, classifying, and processing the multi-omics dataset in a fog cloud network. Based on SARSA on-policy and multi-omics workload learning, made possible by reinforcement learning, the study made new hybrid cancer detection schemes. It consists of different layers, such as clinical data collection via laboratories and tool processes (biopsy, colonoscopy, and mammography) at the distributed omics-based clinics in the network. The study considers the different cancer classes such as carcinomas, sarcomas, leukemias, and lymphomas with their types in work and processes them using the multi-omics distributed clinics in work. In order to solve the problem, the study presents omics cancer workload reinforcement learning state action reward state action "SARSA" (OCWLS) schemes, which are made up of an on-policy learning scheme on different parameters like states, actions, timestamps, reward, accuracy, and processing time constraints. The goal is to process multiple cancer classes and workload feature matching while reducing the time it takes to process in clinical hospitals that are spread out. Simulation results show that OCWLS is better than other machine learning methods regarding+ processing time, extracting features from multiple classes of cancer, and matching in the system.